HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

More Asbestos-Linked Makeup Recalls Ring Regulatory Legislation Bell Again

Executive Summary

Claire’s Stores Inc. voluntarily recalled one lot of JoJo Siwa Makeup Set and private-label manufacturer Beauty Plus Global Inc. recalled one lot of Contour Effects Palette 2. House Energy and Commerce Committee Chairman Frank Pallone says it is “unacceptable” for FDA to rely on voluntary recalls and he is working on legislation that would overhaul cosmetics regulations and give agency mandatory recall authority.

You may also be interested in...



FDA Final Report: Asbestos Detected In 17% Of Talc-Containing Cosmetics, Including Products Previously Under Suspicion

NGOs including the Environmental Working Group maintain that the FDA’s testing results released on 9 March, showing traces of asbestos in nine out of 52 talc-containing cosmetics, signal a need for congressional action to tighten industry oversight. The FDA says the findings are not necessarily representative of the overall marketplace, with further talc testing planned for 2020.

DeLauro Renews Push To Give FDA Mandatory Recall Authority For Drugs

"FDA’s failure to stop companies from selling ranitidine makes the United States government complicit in exposing infants and adults to the risk of cancer," says Rep. DeLauro in letter to FDA and HHS. She also re-introduced legislation proposing FDA have mandatory recall authority for drugs.

OTC Heartburn Remedy Options Remain Robust Without Ranitidine

FDA advising consumers to choose other heartburn OTCs but isn't ordering ranitidine off market. Consumers concerned about Johnson's Baby Powder due to potential asbestos can choose not only from other brands, but also from Johnson's in containers other than 22-ounce option on recall.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148900

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel